Samsung Medison, the medical device unit of Samsung Electronics specializing in diagnostic imaging devices, has announced plans to acquire Sonio, a Paris-based startup renowned for its AI-powered software designed for ultrasound workflows. The acquisition, valued at approximately $92.7 million (KRW 126 billion), signifies Samsung Medison’s commitment to advancing AI-driven imaging solutions in the healthcare sector.

Sonio’s AI assistant targets obstetricians and gynecologists, offering assistance in the evaluation and documentation of ultrasound exams. One of its flagship products, Sonio Detect, has received regulatory clearance in the United States from the FDA (Food and Drug Administration) for its innovative use of deep learning algorithms to enhance the image quality of ultrasound scans in real-time.

In a statement, Samsung Medison expressed its intent to leverage Sonio’s software to introduce improved AI-driven imaging workflows to the market. With Samsung Electronics holding a majority stake of 68.45% in Samsung Medison, the acquisition marks a significant investment in the future of medical imaging technology.

Following the acquisition, Sonio will continue to operate as an independent company, maintaining its presence in France and pursuing commercial growth. Co-founded in 2020 by Cecile Brosset and Remi Besson, Sonio has quickly gained recognition for its groundbreaking AI solutions in the medical field. The startup recently secured $14 million in Series A funding led by Cross Border Impact Ventures in August 2023, bringing its total funding to $27.2 million.

Yong Kwan Kim, CEO of Samsung Medison, emphasized the company’s commitment to improving the quality of healthcare through technology. He stated, “Through the acquisition of Sonio, Samsung Medison will continue to deliver upon our promise to improve the quality of people’s lives with technology.” Kim believes that collaboration with Sonio will usher in a new era in prenatal ultrasound examinations, combining best-in-class ultrasound AI technology with advanced reporting capabilities.

Cecile Brosset, CEO of Sonio, expressed enthusiasm about the partnership with Samsung Medison, highlighting the growth opportunities it presents for both companies. She stated, “Samsung Medison’s established global ultrasound business combined with Sonio’s advanced AI creates an exciting growth opportunity for both sides.” Brosset affirmed Sonio’s commitment to advancing medical reporting technology and diagnostic software globally, particularly in underserved healthcare areas.